FineMark National Bank & Trust’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-56
| Closed | -$4K | – | 420 |
|
|
2018
Q2 | $4K | Hold |
56
| – | – | ﹤0.01% | 400 |
|
|
2018
Q1 | $5K | Hold |
56
| – | – | ﹤0.01% | 389 |
|
|
2017
Q4 | $42K | Hold |
56
| – | – | ﹤0.01% | 364 |
|
|
2017
Q3 | $16K | Hold |
56
| – | – | ﹤0.01% | 369 |
|
|
2017
Q2 | $14K | Hold |
56
| – | – | ﹤0.01% | 355 |
|
|
2017
Q1 | $19K | Hold |
56
| – | – | ﹤0.01% | 367 |
|
|
2016
Q4 | $34K | Hold |
56
| – | – | ﹤0.01% | 713 |
|
|
2016
Q3 | $64K | Hold |
56
| – | – | 0.01% | 557 |
|
|
2016
Q2 | $62K | Hold |
56
| – | – | 0.01% | 540 |
|
|
2016
Q1 | $73K | Hold |
56
| – | – | 0.01% | 490 |
|
|
2015
Q4 | $139K | Sell |
56
-75
| -57% | -$186K | 0.02% | 380 |
|
|
2015
Q3 | $145K | Hold |
131
| – | – | 0.02% | 380 |
|
|
2015
Q2 | $132K | Buy |
131
+75
| +134% | +$75.6K | 0.02% | 415 |
|
|
2015
Q1 | $57K | Hold |
56
| – | – | 0.01% | 631 |
|
|
2014
Q4 | $188K | Buy |
56
+46
| +460% | +$154K | 0.03% | 357 |
|
|
2014
Q3 | $29K | Hold |
10
| – | – | ﹤0.01% | 787 |
|
|
2014
Q2 | $37K | Hold |
10
| – | – | 0.01% | 714 |
|
|
2014
Q1 | $54K | Sell |
10
-5
| -33% | -$27K | 0.01% | 591 |
|
|
2013
Q4 | $47K | Sell |
15
-15
| -50% | -$47K | 0.01% | 592 |
|
|
2013
Q3 | $97K | Sell |
30
-9
| -23% | -$29.1K | 0.02% | 430 |
|
|
2013
Q2 | $125K | Buy |
+39
| New | +$125K | 0.04% | 353 |
|